There is a suspicion about the lipid-lowering treatment in a patient with elevated nonalcoholic fatty liver disease-induced transaminase. In this letter, we will cover on this topic.
Keywords: nonalcoholic fatty liver disease, lipid-lowering treatment, elevated transaminaseCopyright © 2025 Archives of the Turkish Society of Cardiology